Literature DB >> 15323135

RHD 1227A is an important genetic marker for RhD(el) individuals.

Jung-Chin Chen1, Tsun-Mei Lin, Yi Lin Chen, Ya-Hui Wang, Ying-Tai Jin, Chung-Tai Yue.   

Abstract

Approximately 30% of apparently Rh- Taiwanese people actually were RhD(el), a rare variant of the Rh system that might carry a grossly intact RHD gene. Several studies have indicated that the RhD(el) trait might be generated by multiple molecular mechanisms. In this study, a total of 294 Taiwanese serologically RhD- blood donors were tested for Rh phenotypes and RHD genotypes. Among them, total RHD deletion, partial RHD gene, and RhD(el) were found in 185 (62.9%), 15 (5.1%), and 94 (32.0%), respectively. The 1227A allele and exon 9 of the RHD gene were found in all 94 RhD(el) donors. The Ccee was the most prevalent phenotype in the RhD(el) group (78/94 [83%]), and the ccee phenotype was highly prevalent in the true D- group (87.6%). RHD 1227A can be used as an important and useful genetic marker for RhD(el). It can be detected easily by a simple, rapid, specific sequence primer-polymerase chain reaction method.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15323135     DOI: 10.1309/3XMF-2NV5-707T-JE7X

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Analysis of density and epitopes of D antigen on the surface of erythrocytes from DEL phenotypic individuals carrying the RHD1227A allele.

Authors:  Juan Gu; An-Yuan Sun; Xue-Dong Wang; Chao-Peng Shao; Zheng Li; Li-Hua Huang; Zhao-Lin Pan; Qing-Ping Wang; Guang-Ming Sun
Journal:  Blood Transfus       Date:  2013-11-21       Impact factor: 3.443

2.  DEL phenotype.

Authors:  Dong H Kwon; S G Sandler; Willy A Flegel
Journal:  Immunohematology       Date:  2017-09

3.  Screening for DEL phenotype in RhD negative Indians.

Authors:  Swati Kulkarni; Disha S Parchure; Vidya Gopalkrishnan; Manisha Madkaikar
Journal:  J Clin Lab Anal       Date:  2017-06-23       Impact factor: 2.352

4.  An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.

Authors:  Qing-Ping Wang; Guang-Tao Dong; Xue-Dong Wang; Juan Gu; Zheng Li; An-Yuan Sun; Chao-Peng Shao; Zhao-Lin Pan; Li-Hua Huang; Wei-Xing Xie; Guang-Ming Sun; Jian-Jiang Chen; Hao Pei; Xiao-Juan Yang; Ping-Nan Shan
Journal:  Blood Transfus       Date:  2013-02-06       Impact factor: 3.443

5.  DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness.

Authors:  Chao-peng Shao; Bao-yan Wang; Shi-hui Ye; Wen-li Zhang; Hua Xu; Nai-bao Zhuang; Xiao-ying Wu; Heng-gui Xu
Journal:  J Zhejiang Univ Sci B       Date:  2012-11       Impact factor: 3.066

6.  Recommendations Regarding Practical DEL Typing Strategies for Serologically D-Negative Asian Donors.

Authors:  Tae Yeul Kim; Yun Ji Hong; Mi Jung Kim; Hyungsuk Kim; Taek Soo Kim; Jeong Su Park; Kyoung Un Park; Kyou-Sup Han
Journal:  Transfus Med Hemother       Date:  2019-05-17       Impact factor: 3.747

7.  Comparison of real-time polymerase chain reaction assay methods for detection of RHD gene in amniotic fluid.

Authors:  Tuba Gunel; Ibrahim Kalelıoglu; Yusuf Surmelı; Basak Turken; Hayri Ermıs; Kılıç Aydınlı
Journal:  J Nat Sci Biol Med       Date:  2011-07

Review 8.  DEL in China: the D antigen among serologic RhD-negative individuals.

Authors:  Qinan Yin; Willy Albert Flegel
Journal:  J Transl Med       Date:  2021-10-20       Impact factor: 5.531

9.  RhC Phenotyping, Adsorption/Elution Test, and SSP-PCR: The Combined Test for D-Elute Phenotype Screening in Thai RhD-Negative Blood Donors.

Authors:  Songsak Srijinda; Chamaiporn Suwanasophon; Unchalee Visawapoka; Malinee Pongsavee
Journal:  ISRN Hematol       Date:  2012-11-14

10.  Elimination of pretransfusion RhD typing at Mackay Memorial Hospital, Taiwan-30-year experience (1988-2017).

Authors:  Marie Lin
Journal:  Vox Sang       Date:  2020-09-20       Impact factor: 2.144

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.